These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16226394)

  • 1. Probability of mediastinal involvement in non-small-cell lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?
    Giraud P; De Rycke Y; Lavole A; Milleron B; Cosset JM; Rosenzweig KE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):127-35. PubMed ID: 16226394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estimation of the probability of mediastinal involvement: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy in non-small-cell lung cancer?].
    Giraud P; De Rycke Y; Minet P; Danhier S; Dubray B; Helfre S; Dauphinot C; Rosenwald JC; Cosset JM
    Cancer Radiother; 2001 Dec; 5(6):725-36. PubMed ID: 11797293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time trends in nodal volumes and motion during radiotherapy for patients with stage III non-small-cell lung cancer.
    Bosmans G; van Baardwijk A; Dekker A; Ollers M; Wanders S; Boersma L; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):139-44. PubMed ID: 17996384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
    Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located.
    Zhao L; Chen M; Ten Haken R; Chetty I; Chapet O; Hayman JA; Kong FM
    Radiother Oncol; 2007 Feb; 82(2):153-9. PubMed ID: 17287040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is sampling really effective in staging non-small cell lung cancer? A prospective study.
    Magnanelli G; Scanagatta P; Benato C; Terzi A; Lonardoni A; Falezza G; Furlan G; Calabrò F
    Chir Ital; 2006; 58(1):19-22. PubMed ID: 16729605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques--a retrospective analysis.
    Kepka L; Bujko K; Zolciak-Siwinska A
    Acta Oncol; 2008; 47(1):95-103. PubMed ID: 17851862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involved-field radiation therapy for inoperable non small-cell lung cancer.
    Rosenzweig KE; Sura S; Jackson A; Yorke E
    J Clin Oncol; 2007 Dec; 25(35):5557-61. PubMed ID: 17984185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non-small-cell lung cancer.
    Yuan S; Meng X; Yu J; Mu D; Chao KS; Zhang J; Zhong W; Yu Y; Wang J; Sun X; Yang G; Wang Y
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):727-34. PubMed ID: 17293231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
    Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Involved-field three-dimensional conformal radiation treatment for stage III non-small-cell lung].
    Yu JM; Sun XD; Li MH; Zhang JD; Yao CP; Liu S; Zhang Z
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):526-9. PubMed ID: 17147119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.
    Belderbos JS; Heemsbergen WD; De Jaeger K; Baas P; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):126-34. PubMed ID: 16904518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does incidental irradiation with doses below 50 gy effectively reduce isolated nodal failures in non-small-cell lung cancer: dose-response relationship.
    Kepka L; Maciejewski B; Withers RH
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1391-6. PubMed ID: 19306748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?
    Chen M; Hayman JA; Ten Haken RK; Tatro D; Fernando S; Kong FM
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):120-6. PubMed ID: 16198503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
    Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
    Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival.
    Veeramachaneni NK; Battafarano RJ; Meyers BF; Zoole JB; Patterson GA
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):466-9. PubMed ID: 18249130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy.
    Sakao Y; Miyamoto H; Yamazaki A; Ou S; Shiomi K; Sonobe S; Sakuraba M
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):543-7. PubMed ID: 16870462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.